• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的冠状动脉支架置入术后使用全身炎症聚集指数预测支架内再狭窄风险

Machine Learning-Based Prediction of In-Stent Restenosis Risk Using Systemic Inflammation Aggregation Index Following Coronary Stent Placement.

作者信息

Hou Ling, Zhao Jinbo, He Ting, Su Ke, Li Yuanhong

机构信息

Department of Central Hospital of Tujia and Miao Autonomous Prefecture, Hubei University of Medicine, Shiyan, Hubei Province, People's Republic of China.

Cardiovascular Disease Center, Central Hospital of Tujia and Miao Autonomous Prefecture, Hubei University of Medicine, Enshi, Hubei Province, People's Republic of China.

出版信息

Risk Manag Healthc Policy. 2024 Jul 5;17:1779-1786. doi: 10.2147/RMHP.S468235. eCollection 2024.

DOI:10.2147/RMHP.S468235
PMID:38989249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11235080/
Abstract

INTRODUCTION

Coronary artery disease (CAD) remains a significant global health challenge, with percutaneous coronary intervention (PCI) being a primary revascularization method. In-stent restenosis (ISR) post-PCI, although reduced, continues to impact patient outcomes. Inflammation and platelet activation play key roles in ISR development, emphasizing the need for accurate risk assessment tools. The systemic inflammation aggregation index (AISI) has shown promise in predicting adverse outcomes in various conditions but has not been studied in relation to ISR.

METHODS

A retrospective observational study included 1712 patients post-drug-eluting stent (DES) implantation. Data collected encompassed demographics, medical history, medication use, laboratory parameters, and angiographic details. AISI, calculated from specific blood cell counts, was evaluated alongside other variables using machine learning models, including random forest, Xgboost, elastic networks, logistic regression, and multilayer perceptron. The optimal model was selected based on performance metrics and further interpreted using variable importance analysis and the SHAP method.

RESULTS

Our study revealed that ISR occurred in 25.8% of patients, with a range of demographic and clinical factors influencing the risk of its development. The random forest model emerged as the most adept in predicting ISR, and AISI featured prominently among the top variables affecting ISR prediction. Notably, higher AISI values were positively correlated with an elevated probability of ISR occurrence. Comparative evaluation and visual analysis of model performance, the random forest model demonstrates high reliability in predicting ISR, with specific metrics including an AUC of 0.9569, accuracy of 0.911, sensitivity of 0.855, PPV of 0.81, and NPV of 0.948.

CONCLUSION

AISI demonstrated itself as a significant independent risk factor for ISR following DES implantation, with an escalation in AISI levels indicating a heightened risk of ISR occurrence.

摘要

引言

冠状动脉疾病(CAD)仍然是一项重大的全球健康挑战,经皮冠状动脉介入治疗(PCI)是主要的血运重建方法。PCI术后支架内再狭窄(ISR)虽有所减少,但仍会影响患者预后。炎症和血小板活化在ISR的发生发展中起关键作用,这凸显了准确风险评估工具的必要性。全身炎症聚集指数(AISI)在预测各种情况下的不良结局方面显示出前景,但尚未针对ISR进行研究。

方法

一项回顾性观察性研究纳入了1712例药物洗脱支架(DES)植入术后患者。收集的数据包括人口统计学、病史、用药情况、实验室参数和血管造影细节。根据特定血细胞计数计算得出的AISI,与其他变量一起使用机器学习模型进行评估,包括随机森林、Xgboost、弹性网络、逻辑回归和多层感知器。根据性能指标选择最佳模型,并使用变量重要性分析和SHAP方法进行进一步解释。

结果

我们的研究显示,25.8%的患者发生了ISR,一系列人口统计学和临床因素影响其发生风险。随机森林模型在预测ISR方面最为擅长,AISI在影响ISR预测的顶级变量中显著突出。值得注意的是,较高的AISI值与ISR发生概率升高呈正相关。对模型性能进行比较评估和可视化分析,随机森林模型在预测ISR方面显示出高可靠性,具体指标包括曲线下面积(AUC)为0.9569、准确率为0.911、灵敏度为0.855、阳性预测值(PPV)为0.81和阴性预测值(NPV)为0.948。

结论

AISI被证明是DES植入术后ISR的一个重要独立危险因素,AISI水平升高表明ISR发生风险增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/a92ef5c03c84/RMHP-17-1779-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/366b361b9fce/RMHP-17-1779-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/b9d17be3a6b7/RMHP-17-1779-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/b2b3d20979ca/RMHP-17-1779-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/5e4d87f5325d/RMHP-17-1779-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/a92ef5c03c84/RMHP-17-1779-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/366b361b9fce/RMHP-17-1779-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/b9d17be3a6b7/RMHP-17-1779-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/b2b3d20979ca/RMHP-17-1779-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/5e4d87f5325d/RMHP-17-1779-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3102/11235080/a92ef5c03c84/RMHP-17-1779-g0005.jpg

相似文献

1
Machine Learning-Based Prediction of In-Stent Restenosis Risk Using Systemic Inflammation Aggregation Index Following Coronary Stent Placement.基于机器学习的冠状动脉支架置入术后使用全身炎症聚集指数预测支架内再狭窄风险
Risk Manag Healthc Policy. 2024 Jul 5;17:1779-1786. doi: 10.2147/RMHP.S468235. eCollection 2024.
2
Using XGBoost for Predicting In-Stent Restenosis Post-DES Implantation: Role of Lymphocyte-to-Monocyte Ratio and Residual Cholesterol.使用XGBoost预测药物洗脱支架植入术后支架内再狭窄:淋巴细胞与单核细胞比值和残余胆固醇的作用
Int J Gen Med. 2024 Aug 9;17:3443-3452. doi: 10.2147/IJGM.S477053. eCollection 2024.
3
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.二代药物洗脱支架置入术后三血管病变患者血运重建和支架内再狭窄的危险因素:回顾性分析。
BMC Cardiovasc Disord. 2021 Sep 17;21(1):446. doi: 10.1186/s12872-021-02259-0.
4
FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.成纤维细胞生长因子 23 与内分泌和代谢失调、心脏和肾脏功能恶化、炎症水平、狭窄程度相关,可独立预测经皮冠状动脉介入治疗(PCI)置入药物洗脱支架后冠心病患者的支架内再狭窄风险。
BMC Cardiovasc Disord. 2021 Jan 7;21(1):24. doi: 10.1186/s12872-020-01839-w.
5
A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents.基于血小板参数、血脂水平和血管造影特征的预测模型,预测冠心病患者药物洗脱支架置入后支架内再狭窄。
Lipids Health Dis. 2021 Sep 29;20(1):118. doi: 10.1186/s12944-021-01553-2.
6
Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.中国南方人群经皮冠状动脉介入治疗后支架内再狭窄的发生率及危险因素。
Eur J Med Res. 2022 Jan 22;27(1):12. doi: 10.1186/s40001-022-00640-z.
7
Systemic immune inflammation index and its implication on in-stent restenosis among patients with acute coronary syndrome.系统免疫炎症指数及其对急性冠状动脉综合征患者支架内再狭窄的影响。
Coron Artery Dis. 2024 May 1;35(3):209-214. doi: 10.1097/MCA.0000000000001325. Epub 2024 Jan 8.
8
Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.三酰甘油-葡萄糖指数与经皮冠状动脉介入治疗药物洗脱支架后急性冠状动脉综合征患者支架内再狭窄相关。
Cardiovasc Diabetol. 2021 Jul 8;20(1):137. doi: 10.1186/s12933-021-01332-4.
9
New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent.接受药物洗脱支架经皮冠状动脉介入治疗的糖尿病患者支架内再狭窄的新预测指标。
J Geriatr Cardiol. 2018 Feb;15(2):137-145. doi: 10.11909/j.issn.1671-5411.2018.02.011.
10
Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.系统免疫炎症指数与急性冠脉综合征患者支架内再狭窄:一项单中心回顾性研究。
Eur J Med Res. 2024 Feb 26;29(1):145. doi: 10.1186/s40001-024-01736-4.

引用本文的文献

1
Association between monocyte-to-lymphocyte ratio and cardiovascular diseases: insights from NHANES data.单核细胞与淋巴细胞比值与心血管疾病之间的关联:来自美国国家健康与营养检查调查(NHANES)数据的见解
Diabetol Metab Syndr. 2025 Mar 24;17(1):98. doi: 10.1186/s13098-025-01640-9.
2
Association Between the Aggregate Index of Systemic Inflammation and Slow Coronary Flow Phenomenon in Patients with Ischemia and No Obstructive Coronary Arteries.无阻塞性冠状动脉疾病的缺血患者全身炎症综合指数与冠状动脉血流缓慢现象之间的关联
Int J Gen Med. 2025 Mar 12;18:1431-1438. doi: 10.2147/IJGM.S515822. eCollection 2025.
3
Hydrogel-based cardiac patches for myocardial infarction therapy: Recent advances and challenges.

本文引用的文献

1
Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis.新冠病毒肺炎中全身炎症综合指数(AISI)、疾病严重程度和死亡率:一项系统评价与荟萃分析
J Clin Med. 2023 Jul 10;12(14):4584. doi: 10.3390/jcm12144584.
2
The systemic inflammation indexes predict all-cause mortality in peritoneal dialysis patients.系统炎症指标可预测腹膜透析患者的全因死亡率。
Ren Fail. 2023 Dec;45(1):2160348. doi: 10.1080/0886022X.2022.2160348.
3
The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension.
用于心肌梗死治疗的水凝胶基心脏贴片:最新进展与挑战
Mater Today Bio. 2024 Nov 7;29:101331. doi: 10.1016/j.mtbio.2024.101331. eCollection 2024 Dec.
4
The Predictive Value of Perioperative Inflammatory Indexes in Major Arterial Surgical Revascularization from Leriche Syndrome.围手术期炎症指标在莱里什综合征主要动脉手术血运重建中的预测价值
J Clin Med. 2024 Oct 23;13(21):6338. doi: 10.3390/jcm13216338.
5
Prediction Model for in-Stent Restenosis Post-PCI Based on Boruta Algorithm and Deep Learning: The Role of Blood Cholesterol and Lymphocyte Ratio.基于Boruta算法和深度学习的经皮冠状动脉介入治疗后支架内再狭窄预测模型:血液胆固醇和淋巴细胞比率的作用
J Multidiscip Healthc. 2024 Oct 10;17:4731-4739. doi: 10.2147/JMDH.S487511. eCollection 2024.
6
Effect of inflammatory factors on myocardial infarction.炎症因子对心肌梗死的影响。
BMC Cardiovasc Disord. 2024 Oct 7;24(1):538. doi: 10.1186/s12872-024-04122-4.
全身炎症综合指数(AISI):高血压的一种新型预测指标。
Front Cardiovasc Med. 2023 May 17;10:1163900. doi: 10.3389/fcvm.2023.1163900. eCollection 2023.
4
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.钠-葡萄糖协同转运蛋白 2 抑制剂与急性心肌梗死后支架内再狭窄相关事件:2 型糖尿病患者的观察性研究。
BMC Med. 2023 Feb 24;21(1):71. doi: 10.1186/s12916-023-02781-2.
5
Systemic Inflammation Markers Associated with Bone Mineral Density in perimenopausal and Postmenopausal Women.围绝经期和绝经后女性中与骨密度相关的全身炎症标志物
J Inflamm Res. 2023 Jan 22;16:297-309. doi: 10.2147/JIR.S385220. eCollection 2023.
6
Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.外周血淋巴细胞计数可明确抗MDA5阳性皮肌炎患者的临床表型及预后。
J Intern Med. 2023 Apr;293(4):494-507. doi: 10.1111/joim.13607. Epub 2023 Feb 2.
7
Systemic Inflammation is Associated with Cardiometabolic Risk Factors and Clinical Outcomes.全身炎症与心血管代谢危险因素及临床结局相关。
J Inflamm Res. 2022 Dec 29;15:6891-6903. doi: 10.2147/JIR.S382620. eCollection 2022.
8
A multiphysics modeling approach for in-stent restenosis: Theoretical aspects and finite element implementation.一种用于支架内再狭窄的多物理场建模方法:理论方面与有限元实现。
Comput Biol Med. 2022 Nov;150:106166. doi: 10.1016/j.compbiomed.2022.106166. Epub 2022 Oct 6.
9
Procoagulant platelets: novel players in thromboinflammation.促凝血小板:血栓炎症中的新角色。
Am J Physiol Cell Physiol. 2022 Oct 1;323(4):C951-C958. doi: 10.1152/ajpcell.00252.2022. Epub 2022 Aug 22.
10
Coronary In-Stent Restenosis: JACC State-of-the-Art Review.冠状动脉支架内再狭窄:JACC 最新综述
J Am Coll Cardiol. 2022 Jul 26;80(4):348-372. doi: 10.1016/j.jacc.2022.05.017.